Board of Directors

Richard K. Gordon.
Chairman Of The Board
Richard K. Gordon is the general partner of Juniper Capital L.P., Juniper Energy LP and JunCap Trona, L.P., and is a partner in Juniper Capital II, L.P. These partnerships have made in excess of $2.5 billion of investments in oil and gas exploration and production assets, in natural gas pipelines, in oilfield services businesses, in natural gas fired electric generating plants and in mineral royalties. Mr. Gordon is the lead Director and head of the Human Resources Committee of Atmos Energy Corporation, a $7 billion market cap energy company listed on the New York Stock Exchange; he is also a director of ExoStat Medical, Inc. Prior to working with Juniper, Mr. Gordon spent nearly 30 years working in the financial services industry with Dillon, Read & Co., Inc. where he was a Vice President, The First Boston Corporation where he was a Managing Director and Merrill Lynch & Co., Inc. where he was a Vice Chairman of Investment Banking. Mr. Gordon has founded or co-founded more than 15 companies engaged in such diverse industries as energy, power generation, leasing, telecommunications, real estate, food and beverage, and medical devices. Mr. Gordon holds a B.A. degree from Colgate University and an M.B.A. degree from Cornell University.

Hayden R, Fleming
Co-Founder and Board Member
Mr. Fleming has been active in the development of ExoStat Medical, Inc. since its formation in August, 2009. From 1996~2011, Mr. Fleming was Owner and President of the brokerage firm, Fleming Securities, Inc. During that time, Mr. Fleming was also Manager of two private investment funds, Circle F Ventures, LLC and Circle F Ventures II, LLC, both of which made investments in companies in various industries and of various sizes. Mr. Fleming is a founder, Chairman of the Board and CEO of Resuscitation International, LLC which Is an early stage resuscitation company specializing in mechanical CPR. Mr. Fleming also serves on the board of Data Transfer of Nevada, LLC. Prior to 1996, Mr. Fleming was active in structuring and selling private placements and new public issues for various start-up and early stage companies. Mr. Fleming attended St. Cloud State University but his studies were interrupted due to military service in Vietnam.

David C. Gordon
Board Member
Mr. Gordon has provided investment banking services to the healthcare industry for over 25 years.  Mr. Gordon has represented both not-for-profit and investor-owned companies and has extensive experience working with general acute care hospitals, long-term care facilities, specialty hospitals, physician practices, HMO’s and medical office buildings.  Mr. Gordon is Co-Founder of Juniper Advisory, LLC in Chicago, IL.  Prior to forming Juniper in 2006, Mr. Gordon co-led the healthcare M&A group of Ponder & Co. (2001–2006) and the healthcare services group at U.S. Bancorp/Piper Jaffray (1998–2001).  Prior to rejoining Nuveen in 1998, Mr. Gordon was the Managing Director in charge of investment banking healthcare services for ABN AMRO, Inc. North America.  While at ABN his group provided financial advisory services and secured private and public equity for healthcare clients.  From 1986–1996, Mr. Gordon worked with Nuveen where he specialized in the firm’s healthcare, merger, acquisition, and divestiture practice.  From 1979–1986, Mr. Gordon was employed by Ernst & Young in Chicago providing consulting services.  His engagement experience, while with Ernst & Young, concentrated on M&A for middle-sized commercial companies and financial institutions.  In addition, he was involved in various aspects of strategic and capital planning for large national and multi-national corporations.  Mr. Gordon holds a B.A. from Ohio Wesleyan University (1977) and an M.B.A. from University of Notre Dame (1979).

James R. Hays, Jr.
President/Chief Executive Officer,Board Member
Mr. Hays has served ExoStat Medical, Inc. as President and CEO since mid-2012 and was one of the early investors. Prior to his ExoStat involvement, Mr. Hays had been active as management, investor, and/ or Board member in a myriad of private startup and early stage businesses in various industries including: oil and gas drilling; oil and gas distribution; gas gathering and processing; oil field service and supplies; commercial banking; commercial insurance; high speed postal sorting technology; restaurant ownership; country club acquisition and operations; and medical device research and development. His business experience spans 45 years. ExoStat is his seventh start up venture. Mr. Hays authored several published business/Industry papers, has been featured in national business publications, and in May, 2013, was interviewed on a national program called "The Story" for NPR radio network. In 1991, Mr. Hays sold MEGA Natural Gas Co., where he was Co-Founder, Chairman, and CEO. At that time, MEGA was one of the largest gatherers and marketers of natural gas in Oklahoma. Due to a non-compete clause as part of the MEGA merger agreement, Mr. Hays deviated from the business world to play professional golf on the US Senior PGA tour and the European Senior PGA tour until he retired in 1999. At that time, Mr. Hays once again became actively involved in several business startups, primarily in the medical R&D space. He has served on multiple charity and church Boards in his career.   Mr. Hays was recently appointed to the International Business Leaders Council, a task force created to advise the leaders of the Catholic Church in Rome and to provide guidance on the curriculum for the advanced business/finance education to seminarians at Santa Croce University, Rome. Additionally, Mr. Hays serves on the Steering Committee to the Industrial Research and Development group, a participant in Innovation Norway, a collaborative product development project in Oslo, Norway. Mr. Hays holds a BS/BA in Economics and Accounting from Oklahoma State University.

Stein lvar Hansen
Board Member
Dr. Hansen has more than 25 years of experience in micro/nano sensor research and development projects from both the technical side and the business development side. Dr. Hansen is currently Chairman of the Board of Sensocure, AS, a Norwegian development/ business partner of ExoStat Medical. Sensocure develops and sells sensors for medical use worldwide. In 2010, Dr. Hansen became, and remains, CEO of Microtech Innovation, a lead company in the business incubator known as the Norwegian Centres of Expertise in Micro and Nano Technologies, located in Vestfold, Norway. Prior to accepting the Microtech Innovation position, Dr. Hansen was Professor of Microsystems at the lnstititute of Micro and Nano Systems Technology (IMST), also located in Vestfold, Norway. From 2003- 2006, Dr. Hansen was Industry Attache’ for Norway while living in Boston, Massachusetts. Other positions held include Vice President for Sensonor Norway and Senior Scientist at Telenor (Norwegian Telecom Research). Dr. Hansen currently serves on several other Boards. He holds a Bachelor of Science (with honors) in Electronic Systems and Microcomputer Engineering, a Masters of Science in Optical Communications Systems, and a Ph.D. In Quantum Well Integrated Optoelectric Devices (University of Glasgow, Scotland).

D. Gordon
H. Fleming
S. Hansen
R. Gordon
J. Hays